logo
Select company
Select metric
Ticker Information

Ticker

OGEN

Company Name

ORAGENICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

ORAGENICS INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

OGEN - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ -2.13M$ -10.3M0%
3/31/2025$ 137.69K$ -10.33M-7505.43%
12/31/2024$ -211.88K$ -10.57M0%
9/30/2024$ 3.08M$ -19.97M-648.76%
6/30/2024$ 1.33M$ -19.52M-1471.37%
3/31/2024$ 2.63M$ -20.26M-771.8%
12/31/2023$ 3.17M$ -20.66M-651.98%
9/30/2023$ 6.5M$ -10.15M-156.16%
6/30/2023$ 7.26M$ -12M-165.39%
3/31/2023$ 10.24M$ -12.54M-122.43%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for ORAGENICS INC is calculated as follows: Net Inc. Cmn. [ $ -25.62M ] / Equity [ $ 9.64M ]
(=) ROE [ -265.75% ]

OGEN - Return on Equity, Last 5 years

-7505.43%

Minimum

Mar 31, 2025

-54.81%

Maximum

Jun 30, 2021

-698.78%

Average

-139.29%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.13K
min-66.24%
max73.25%
average1.63%
median6.53%
std22.52%